Chargement en cours...

Extracellular Hsp90 (eHsp90) as the Actual Target in Clinical Trials: Intentionally or Unintentionally

Despite extensive investigative studies and clinical trials over the past two decades, we still do not understand why cancer cells are more sensitive to the cellular toxicity of Hsp90 inhibitors than normal cells. We still do not understand why only some cancer cells are sensitive to the Hsp90 inhib...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Li, Wei, Tsen, Fred, Sahu, Divya, Bhatia, Ayesha, Chen, Mei, Multhoff, Gabriele, Woodley, David T.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4023563/
https://ncbi.nlm.nih.gov/pubmed/23445811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/B978-0-12-407697-6.00005-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!